Researchers Probe New Territory in Treating Patients with Lung Cancer during COVID-19 Pandemic
January 29, 2021 15:45 ET
|
International Association for the Study of Lung Cancer
Press Briefing with International Researchers Explores this Question at IASLC 2020 World Conference on Lung Cancer Singapore To view a recording of the press briefing, visit:...
Lung Cancer Care and Research Not Immune to Socioeconomic, Ethnic, Racial, and Gender-related Factors that Create Disparities
January 28, 2021 19:19 ET
|
International Association for the Study of Lung Cancer
SINGAPORE, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Several leading international lung cancer researchers at a press today presented compelling new data revealing that factors of race, gender, sexual...
Sotorasib Provides Durable Clinical Benefit for Patients with NSCLC and KRAS Mutations
January 28, 2021 15:10 ET
|
International Association for the Study of Lung Cancer
SINGAPORE, Jan. 28, 2021 (GLOBE NEWSWIRE) -- In the phase II CodeBreak 100 trial, sotorasib provided durable clinical benefit with a favorable safety profile in patients with pretreated non-small...
Lung cancer researchers present new clinical trial data at International Association for the Study of Lung Cancer World Conference on Lung Cancer Virtual Presidential Symposium
August 08, 2020 07:00 ET
|
International Association for the Study of Lung Cancer
DENVER, Aug. 08, 2020 (GLOBE NEWSWIRE) -- The combination of first-line nivolumab and ipilimumab demonstrated an improvement of overall survival for patients with unresectable malignant pleural...